Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Par Drugs IPO and Suich Industries IPO.
Par Drugs IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Suich Industries IPO is a SME Book Built Issue proposed to list at BSE SME.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | Pantomath Capital Advisors Pvt Ltd |
| Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Par Drugs IPO is up to ₹8.53 Cr whereas the issue size of the Suich Industries IPO is up to ₹30.86 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Suich Industries IPO is ₹75.00 per share.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹73.00 per share | |
| Issue Price (Upper) | ₹75.00 per share | |
| Issue Price (Final) | ₹51.00 per share | ₹75.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 16,72,000 shares | |
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 16,72,000 shares | 41,15,200 shares |
| Issue Size Total (Amount) | up to ₹8.53 Cr | up to ₹30.86 Cr |
Par Drugs IPO opens on May 03, 2019, while Suich Industries IPO opens on May 30, 2019. The closing date of Par Drugs IPO and Suich Industries IPO is May 08, 2019, and Jun 04, 2019, respectively.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 03, 2019 | May 30, 2019 |
| Issue Close | May 08, 2019 | Jun 04, 2019 |
| Basis Of Allotment (Tentative) | May 13, 2019 | Jun 10, 2019 |
| Initiation of Refunds (Tentative) | May 14, 2019 | Jun 11, 2019 |
| Credit of Share (Tentative) | May 15, 2019 | Jun 12, 2019 |
| Listing date (Tentative) | May 16, 2019 | Jun 13, 2019 |
| Anchor Lockin End date 1 | Jun 12, 2019 | Jul 10, 2019 |
| Anchor Lockin End date 2 | Aug 11, 2019 | Sep 08, 2019 |
Par Drugs IPO P/E ratio is , as compared to Suich Industries IPO P/E ratio of .
| Par Drugs IPO | Suich Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.55% | 95.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.82 | 69.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Par Drugs IPO retail investors (RII) are offered 7,80,000 shares while in Suich Industries IPO retail investors are offered 7,80,000 shares. Qualified institutional buyers (QIB) are offered in Par Drugs IPO and in Suich Industries IPO.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 84,000 shares | 2,08,000 shares |
| QIB | ||
| NII | 7,78,000 shares | 19,53,600 shares |
| RII | 7,80,000 shares | 19,53,600 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 15,58,000 shares | 39,07,200 shares |
Par Drugs IPO subscribed 5.74x in total, whereas Suich Industries IPO subscribed 1.39x.
| Par Drugs IPO | Suich Industries IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.48x | 1.32x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.97x | 1.47x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 5.74x | 1.39x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
